Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Glück et al

Arthritis Rheum. 2003 Jun;48(6):1764-5; author reply 1765-6. doi: 10.1002/art.11019.
No abstract available

Publication types

  • Case Reports
  • Comment
  • Letter

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / immunology*
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / immunology
  • Arthritis, Psoriatic / complications
  • Arthritis, Psoriatic / drug therapy*
  • Drug Therapy, Combination
  • Humans
  • Immunocompromised Host
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / immunology
  • Indomethacin / therapeutic use
  • Infliximab
  • Listeria monocytogenes / isolation & purification*
  • Listeria monocytogenes / pathogenicity
  • Listeriosis / drug therapy
  • Listeriosis / etiology*
  • Listeriosis / immunology
  • Male
  • Middle Aged
  • Prednisolone / therapeutic use
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • Anti-Bacterial Agents
  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Prednisolone
  • Infliximab
  • Indomethacin